Moffitt Cancer Center - Invidious

Moffitt Cancer Center

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 8,000 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-663-3488, visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.

View channel on YouTube

Switch Invidious Instance

Videos

newest

oldest

popular

3:37

2025 Magnolia Ball Patient Testimonial: Bob Snedeker

Moffitt Cancer Center

Shared 2 days ago

71 views

36:11

Cristina Naso - Conectados por Tu Salud

Moffitt Cancer Center

Shared 1 week ago

120 views

2:03

The Cancer Cookbook: Garlic Greens and Mushrooms

Moffitt Cancer Center

Shared 1 week ago

69 views

1:05:11

An Insider's Look: Innovations in Malignant Hematology Research

Moffitt Cancer Center

Shared 2 weeks ago

392 views

2:39

The Cancer Cookbook: Salmon Fillet with Yogurt Avocado Sauce

Moffitt Cancer Center

Shared 3 weeks ago

194 views

1:01

SouthShore Grand Opening - Moffitt Cancer Center

Moffitt Cancer Center

Shared 3 weeks ago

638 views

12:26

Randy Isaacson: Leukemia Was Only 162 Days of Our Amazing Life

Moffitt Cancer Center

Shared 4 weeks ago

84 views

4:17

Thoracic Cancer Treatment with Dr. Sam Freyaldenhoven

Moffitt Cancer Center

Shared 1 month ago

160 views

2:03

Gifts of Gratitude 2024 - Moffitt Cancer Center

Moffitt Cancer Center

Shared 1 month ago

1.1K views

2:39

Moffitt Cancer Center Treats First Synovial Sarcoma Patient with FDA Approved Cell Therapy

Moffitt Cancer Center

Shared 1 month ago

155 views

35:31

Dr. Matt Schabath - Bringing your whole self

Moffitt Cancer Center

Shared 1 month ago

90 views

32:47

LIVE: The 2024 ReMissions Holiday Sing-Along from Moffitt Cancer Center

Moffitt Cancer Center

Shared 1 month ago

498 views

2:39

ASH 2024: Ziad Abuhelwa, MD Discusses Outcomes in MDS Patients Comparing IDH1-MT vs. Wild-Type

Moffitt Cancer Center

Shared 1 month ago

57 views

1:22

ASH 2024: Praneeth Reddy Sudalagunta, PhD on Bridging MM Therapy Effects with Idecabtagene-Vicleucel

Moffitt Cancer Center

Shared 1 month ago

35 views

2:45

ASH 2024: Abida Babu on Fludarabine-Melphalan vs. Fludarabine-Busulfan in AML Transplant Outcomes

Moffitt Cancer Center

Shared 1 month ago

60 views

2:00

ASH 2024: Wael Gamal, PhD on PI3K Inhibition to Enhance CAR T-Cell Therapy in CLL

Moffitt Cancer Center

Shared 1 month ago

67 views

2:42

ASH 2024: Bijal Shah, MD on Healthcare Costs and Resource Use in Managing CRS/ICANS with ObeCART

Moffitt Cancer Center

Shared 1 month ago

40 views

2:38

ASH 2024: David Sallman, MD on MRD Evaluation via NGS with CPX-351 in Acute Myeloid Leukemia

Moffitt Cancer Center

Shared 1 month ago

61 views

4:34

ASH 2024: Jeremy DiGennaro, DO on Pacritinib, Momelotinib Use and Outcomes in Myelofibrosis

Moffitt Cancer Center

Shared 1 month ago

51 views

2:59

ASH 2024: Nelli Bejanyan, MD on Donor Gamma Delta T-Cell Therapy to Prevent AML Relapse

Moffitt Cancer Center

Shared 1 month ago

73 views

3:01

ASH 2024: Ziad Abuhelwa, MD on Patterns & Outcomes in Myeloma After Anti-BCMA CAR T Therapy

Moffitt Cancer Center

Shared 1 month ago

126 views

4:29

ASH 2024: Faustine Ong, MD Discusses Disparities in AML Survival in the Targeted Therapy Era

Moffitt Cancer Center

Shared 1 month ago

60 views

1:49

ASH 2024: Ciara Freeman, MD on New CAR T Therapy with High Success & Manageable Side Effects

Moffitt Cancer Center

Shared 1 month ago

45 views

4:14

ASH 2024: Hammad Tashkandi, MD on TP53-Mutated MDS Subgrouping & Prognostic Insights from WHO & ICC

Moffitt Cancer Center

Shared 1 month ago

37 views

2:54

ASH 2024: Lauren Peres, PhD Highlights Racial & Ethnic Outcomes in Multiple Myeloma CAR-T Therapy

Moffitt Cancer Center

Shared 1 month ago

18 views

1:59

ASH 2024: Doris Hansen, MD on Toxicity & Response in Idecabtagene Vicleucel Therapy

Moffitt Cancer Center

Shared 1 month ago

15 views

2:47

ASH 2024: Dr. Sameh Gaballa, MD on High Response Rates with AZD0486 in Relapsed/Refractory DLBCL

Moffitt Cancer Center

Shared 1 month ago

47 views

1:21

ASH 2024: Doris Hansen, MD on Ide and Cilta-cel in Relapsed/Refractory Multiple Myeloma

Moffitt Cancer Center

Shared 1 month ago

66 views

1:50

ASH 2024: Onyee Chan, MD on Defining Intolerance to Tyrosine Kinase Inhibitor Treatment

Moffitt Cancer Center

Shared 1 month ago

19 views

11:58

Lloyd Goldstein: A Bridge Between Hearts

Moffitt Cancer Center

Shared 1 month ago

31 views

1:22

ASH 2024: Onyee Chan, MD Presented Phase 1 Study: CPX-351 + Gemtuzumab in AML Treatment

Moffitt Cancer Center

Shared 1 month ago

26 views

3:53

ASH 2024: Hayder Saeed, MD Presented Phase 1 Study of Duvelisib in Combination Oral Azacitdine

Moffitt Cancer Center

Shared 1 month ago

37 views

1:46

ASH 2024: Moazzam Shahzad, MD Discusses Bleeding and Thrombotic Complications of JAK Inhibitors

Moffitt Cancer Center

Shared 1 month ago

40 views

1:04

ASH 2024: Bijal Shah, MD Presents on the Blinatumomab + Ponatinib Effective in Ph+ ALL & CML

Moffitt Cancer Center

Shared 1 month ago

70 views

2:14

ASH 2024: Shrinjaya Thapa, MD Shared Outcomes in MYD88 + Waldenström Macroglobuliemia Patients

Moffitt Cancer Center

Shared 1 month ago

44 views

1:26

ASH 2024: Dr. Onyee Chan on Phase 1 Study of CPX-351 + Gilteritinib in FLT3-Mutated AML

Moffitt Cancer Center

Shared 1 month ago

19 views

6:31

ASH 2024: Mark Meads, PhD Presented Immune Evasion Linked to Daratumumab Resistance in NDMM

Moffitt Cancer Center

Shared 1 month ago

39 views

1:43

Business of Biotech 2024

Moffitt Cancer Center

Shared 1 month ago

116 views

2:23

ASH 2024: Ken Phong Duy Dao Shared Inflammatory Transcriptional Signature in De Novo & Secondary AML

Moffitt Cancer Center

Shared 1 month ago

26 views

4:02

ASH 2024: Drs. David Sallman and Jeff Lancet Discuss Measurable Residual Disease in AML and MDS

Moffitt Cancer Center

Shared 1 month ago

54 views

3:19

ASH 2024: Jeremy DiGennaro, DO Discusses High-Risk MDS Treated Hypomethylation Agent and Venetoclax

Moffitt Cancer Center

Shared 1 month ago

38 views

4:50

ASH 2024: Sadegh Marzban, PhD Discusses Mechanistic Learning: Boosting Disease Prediction & Insights

Moffitt Cancer Center

Shared 1 month ago

117 views

4:18

ASH 2024: Fatima Tuz Zahra Presents Outcomes of Oral Azacitidine Maintenance Therapy for AML

Moffitt Cancer Center

Shared 1 month ago

35 views

2:52

ASH 2024: Dr. Hany Elmariah Discusses Latest Cellular Immunotherapies to Treat Hematologic Cancers

Moffitt Cancer Center

Shared 1 month ago

67 views

2:37

ASH 2024: Drs. Onyee Chan and Jeffrey Lancet Siscuss the Growth of Target Therapies for AML

Moffitt Cancer Center

Shared 1 month ago

38 views

0:48

ASH 2024: Andrew Kuykendall, MD Shares Fedratinib Could Offer New Option for MDS/MDS & CNL patients

Moffitt Cancer Center

Shared 1 month ago

32 views

1:42

ASH 2024: Wael Gamal PhD Discusses Endoplasmic Reticulum Stress in CLL T-cell Dysfunction

Moffitt Cancer Center

Shared 1 month ago

28 views

2:41

ASH 2024: Jena Schmitz Discusses How Letermovir Cuts CMV Risk in Allogeneic Transplant Patients

Moffitt Cancer Center

Shared 1 month ago

35 views

3:22

ASH 2024: Drs. Ariel Grajales Cruz and Jeff Lancet Discuss Bispecific Multiple Myeloma Antibodies

Moffitt Cancer Center

Shared 1 month ago

108 views

1:47

ASH 2024: Dr. Rachid Baz Discusses a Personalized Daratumumab-Based Response Adapted Therapy

Moffitt Cancer Center

Shared 1 month ago

48 views

2:16

ASH 2024: Dr. Fnu Amisha Discusses Predictive Markers After BCMA CAR T Therapy in RRMM Patients

Moffitt Cancer Center

Shared 1 month ago

73 views

5:14

ASH 2024: Drs. Rami Komrokji and Jeff Lancet Discuss Myelodysplastic Syndrome Treatments

Moffitt Cancer Center

Shared 1 month ago

58 views

5:06

ASH 2024: Drs. Julio Chavez and Jeffrey Lancet Discuss Advancements in Targeted Lymphoma Therapies

Moffitt Cancer Center

Shared 1 month ago

55 views

4:39

ASH 2024: Drs. Brandon Blue & Jeff Lancet Discuss Racial Disparities & Multiple Myeloma Advances

Moffitt Cancer Center

Shared 1 month ago

79 views

1:08

ASH 2024: Zhuoer Xie Shares New Study Compares CCUS vs Lower-Risk MDS Insights for Personalized Care

Moffitt Cancer Center

Shared 1 month ago

62 views

3:45

Daytime with Dr. Daniel Anaya

Moffitt Cancer Center

Shared 1 month ago

83 views

1:00

Moffitt Cancer Center | Above The Rest 60

Moffitt Cancer Center

Shared 2 months ago

168 views

0:16

Moffitt Cancer Center | Above The Rest 15B

Moffitt Cancer Center

Shared 2 months ago

158K views

0:16

Moffitt Cancer Center | Above The Rest 15A

Moffitt Cancer Center

Shared 2 months ago

302K views

2:26

Miles for Moffitt 2024

Moffitt Cancer Center

Shared 2 months ago

123 views